Isturisa Tablets 5mg, manufactured by Recordati Rare Diseases Japan, contain Osilodrostat Phosphate. This medication treats adults with endogenous Cushing’s syndrome, a condition characterized by excessive cortisol production, by inhibiting a key enzyme in the adrenal glands. YJ code: 2499015F2022, Standard: 5mg 1 tablet.
Isturisa Tablets 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
